Michael Scolaro

Michael Scolaro

Nov 19, 2017

Group 6 Copy 168
3
Please wait...

About This Project

We have invented a Nanocarrier that targets the Immune System to deliver Curcumin, an anti-inflammatory agent, to the brain for the treatment of neurodegenerative diseases, such as Chronic Traumatic Encephalopathy.

Our preclinical study at Charles River Labs and the U. of Arizona, is being conducted to establish proof of effective nanocarrier delivery of Curcumin to the cells of the brain damaged by repeated traumatic athletic injuries to the head.

Blast off!

Browse Other Projects on Experiment

Related Projects

Next Generation Non-Seeing Eye Prosthesis

This project aims to push the current state of the art in ocular prothestics by integrating a small system of...

Rapid Detection of Tuberculosis -SCSU-New Haven iGEM

The World Health Organization reports 9.6 million new Tuberculosis cases in 2014. As a global health issue one...

Early-Stage Drug Discovery for Chagas' Disease

An estimated 6 – 7 million people in Latin America and 300,000 U.S. citizens are infected with the protozoan...

Backer Badge Funded